Female Contraception Clinical Trial
Official title:
Mirena and Amenorrhea Related acceptabILity in Contraception indIcAtion
MARILIA is a prospective, non-interventional, multicenter study. The purpose of this study is to describe the acceptability of Amenorrhea in contraception indication of Mirena users during one year follow up in medical practice. 500 patients in 20 centers will be enrolled in the study. Bleeding profile, removal or non-removal of the IUS (IntraUterine System) will be evaluated.
n/a
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06394999 -
Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive
|
Phase 3 | |
| Completed |
NCT00653016 -
An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method
|
Phase 4 | |
| Completed |
NCT00511784 -
Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.
|
N/A | |
| Completed |
NCT00236769 -
A Study of Efficacy and Safety With the Transdermal Contraceptive System.
|
Phase 3 | |
| Active, not recruiting |
NCT03124160 -
Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard
|
Phase 3 | |
| Completed |
NCT00709189 -
Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.
|
Phase 1 | |
| Completed |
NCT00775086 -
Bioequivalence Study of Patches With Different Equilibration Profiles
|
Phase 1 | |
| Completed |
NCT00258063 -
A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)
|
Phase 1 | |
| Recruiting |
NCT04143659 -
A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception
|
Phase 1 | |
| Completed |
NCT00697307 -
Bioequivalence Study of Patches With Different Release Profiles
|
N/A | |
| Completed |
NCT00261482 -
Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.
|
Phase 4 | |
| Completed |
NCT01286948 -
Prevention of Ovulation Achieved by Single Intra-vaginal Administration of Levogel as Compared to Oral LNG
|
Phase 1 | |
| Completed |
NCT00236795 -
A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.
|
Phase 3 | |
| Recruiting |
NCT02257671 -
Oral Contraceptives and Economic Behaviour
|
N/A | |
| Recruiting |
NCT03432416 -
Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring
|
Phase 2 | |
| Completed |
NCT01178125 -
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
|
Phase 3 | |
| Completed |
NCT00254865 -
A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers
|
Phase 1 | |
| Completed |
NCT00258076 -
A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)
|
Phase 1 | |
| Completed |
NCT00331071 -
Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks
|
N/A | |
| Completed |
NCT00377988 -
A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control
|
N/A |